Objective: Cup therapy has an important place in traditional and complementary medicine applications. The purpose of our study, this is the first time to investigate the protective effect of cup therapy in rats on experimentally generated epileptic seizures in new rat modeling created by different anatomic regions. Methods: A total of 42 Wistar albino rats were randomly divided into 6 groups (n:7). The new dry cup was applied to the G1 group, and the new wet cup model was applied to the G2. In the G3 group, an epilepsy model (PTZ, 35 mg / kg) was created and diazepam (2.5 mg / kg) was given to G4. Dry cup and wet cup models were applied to the G5 and G6 groups, respectively. 24 hours after the cupping therapies, the rats were injected with ...
Nowadays, there are various animal models of acute and chronic seizures. Some chemical and electrica...
Background & Objectives: Considering the role of glial cells in synaptic transmission, regulatio...
OBJECTIVE: Epilepsy affects ~50 million people worldwide causing significant medical, financial, and...
Purpose: Vagus nerve stimulation (VNS) is a moderately effective anti-epileptic treatment. Clinicall...
Purpose: To investigate the protective effect of baicalein against chronic seizures in pentylenetetr...
Objectives: To study the possible anti-seizure and neuroprotective effect of glucagon like peptide 1...
Objectives: To validate a method for the chronic implantation of micro-cannulae to examine the effec...
WOS: 000461404200005PubMed ID: 30610970Background: Millions of individuals worldwide suffer from epi...
International audiencePURPOSE: We developed a new in vitro preparation of immature rats, in which in...
BACKGROUND AND OBJECTIVE: Epilepsy is one of the common diseases of the brain that about 30-40 of pa...
Purpose: Mutations in the SCN1A gene, which encodes the alpha 1 subunit of voltage-gated sodium chan...
This article describes current experimental models of status epilepticus (SE) and neuronal injury fo...
BACKGROUND AND OBJECTIVE: Epilepsy is one of the common diseases of the brain that about 30-40% of p...
Background and purpose: Status epilepticus is a severe neurological disorder that can be life-threat...
Pentylenetetrazole (PTZ) and maximal electroshock (MES) models are often used to induce seizures in ...
Nowadays, there are various animal models of acute and chronic seizures. Some chemical and electrica...
Background & Objectives: Considering the role of glial cells in synaptic transmission, regulatio...
OBJECTIVE: Epilepsy affects ~50 million people worldwide causing significant medical, financial, and...
Purpose: Vagus nerve stimulation (VNS) is a moderately effective anti-epileptic treatment. Clinicall...
Purpose: To investigate the protective effect of baicalein against chronic seizures in pentylenetetr...
Objectives: To study the possible anti-seizure and neuroprotective effect of glucagon like peptide 1...
Objectives: To validate a method for the chronic implantation of micro-cannulae to examine the effec...
WOS: 000461404200005PubMed ID: 30610970Background: Millions of individuals worldwide suffer from epi...
International audiencePURPOSE: We developed a new in vitro preparation of immature rats, in which in...
BACKGROUND AND OBJECTIVE: Epilepsy is one of the common diseases of the brain that about 30-40 of pa...
Purpose: Mutations in the SCN1A gene, which encodes the alpha 1 subunit of voltage-gated sodium chan...
This article describes current experimental models of status epilepticus (SE) and neuronal injury fo...
BACKGROUND AND OBJECTIVE: Epilepsy is one of the common diseases of the brain that about 30-40% of p...
Background and purpose: Status epilepticus is a severe neurological disorder that can be life-threat...
Pentylenetetrazole (PTZ) and maximal electroshock (MES) models are often used to induce seizures in ...
Nowadays, there are various animal models of acute and chronic seizures. Some chemical and electrica...
Background & Objectives: Considering the role of glial cells in synaptic transmission, regulatio...
OBJECTIVE: Epilepsy affects ~50 million people worldwide causing significant medical, financial, and...